Empowering healthcare decision-makers:
Accuracy meets speed with FormularyDecisions
In today's fast-paced healthcare landscape, decision-makers are challenged to evaluate biopharma products for new and expanded indications. With over 100 new drugs and 130 new indications approved by the FDA each year, along with thousands of clinical trials and consensus guidelines, the volume and complexity of reviews can be overwhelming.
FormularyDecisions user testimonials:
"At my organization we have a very detailed monograph template, and sometimes it's hard to know where to start. I've recently found that the Product Snapshots on FormularyDecisions can help me get my bearings and quickly understand a new product, which makes starting the monographs a lot less overwhelming."
- Drug Information Pharmacist, Health System
- Drug Information Pharmacist, Health System
"The team I oversee uses FormularyDecisions to find pertinent research instead of utilizing individual sites/web searches. Additionally, the dossier request tool is important -- most of the team doesn't have a relationship with the pharma reps, so having a centralized place to request is much easier than trying to track down a contact with individual manufacturers."
- Vice President, Medicare Part D, Pharmacy Benefits Manager (PBM)
- Vice President, Medicare Part D, Pharmacy Benefits Manager (PBM)
"I'm excited that I don't have to create the Biosimilars table myself, but I'm sad I haven't been using FormularyDecisions this entire time."
- Clinical Pharmacist, Health System
- Clinical Pharmacist, Health System
Evaluate competitive evidence
With FormularyDecisions, you can quickly compare multiple products within a product class. Drug Class Reviews are available to evaluate indications, mechanisms of action, dosing, and adverse events for similar agents.
Acquire product information early
Enhance the way you gather product data via a single, secure 24/7 platform. There are over 3,900 FDA-approved and pipeline products on the platform. Gain compliant access to the information you deem most critical when considering formulary decisions. In addition, there are over 1 million evidence links to leading scientific resources including FDA, CDC, NIH, JAMA, PubMed, and more – offering you a more efficient method to source information in support of your product needs.
Understand the US biosimilars market and laws governing every state
Gain centralized access to all pertinent biosimilar information in the US through the biosimilars hub. The hub provides FDA guidance on biosimilars, manufacturer resources, and serves as an exclusive repository for substitution laws for all 50 states.
Streamline the formulary decision making process
FormularyDecisions is a secure online platform that facilitates the exchange of information between healthcare decision-makers and life sciences companies to provide healthcare decision-makers with the evidence, resources, and tools to support the product evaluation process. With FormularyDecisions, you can quickly access the information you need on thousands of products all from one site.
Connect with manufacturers
More than 500 manufacturers (pharma, biotech, medical device) are featured on the platform providing information that includes disease and therapeutic information, abstracts, posters, monographs, and pivotal clinical studies. eDossiers allow users to automatically access manufacturer product information once it becomes available and easily create customized product monographs.
Determine the cost effectiveness of products
FormularyDecisions is also the home to reports generated by the Institute for Clinical and Economic Review (ICER). ICER Reports assist decision-makers in determining the cost effectiveness of products in specific disease states as compared to similar products.
